Merck Generics Division In Settlement Talks Over Anti-Depressant Drug Patent
New York-based Forest Laboratories Inc. and its Danish licensing partner H. Lundbeck AS are in settlement talks with Australian generic drug maker Alphapharm Pty. Ltd. over its updated antidepressant drug Lexapro,...To view the full article, register now.
Already a subscriber? Click here to view full article